Rm86Texas Protein Vaccine for Tick Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for controlling tick infestations in non-bovine animals, such as deer, are inadequate due to the emergence of pesticide-resistant tick strains and the limited effectiveness of existing arthropod parasite vaccines, particularly for ticks like Rhipicephalus microplus, Ixodes scapularis, and Amblyomma americanum, which pose significant health risks by transmitting tick-borne pathogens.
Innovation Solution
Development of a vaccine using the Rm86Texas protein or its nucleic acid construct, which elicits a protective immune response in non-bovine animals, reducing or eliminating tick infestations and the incidence of tick-borne diseases by immunizing animals against R. microplus and other tick species, including Ixodes scapularis and Amblyomma americanum.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pesticide-based methods are used to control tick infestations, then tick populations can be reduced, but tick strains become resistant and control effectiveness decreases
Solution Approach 1:
The patent converts the harmful effect of tick infestations into a beneficial immunological response by using tick antigens (such as Bm86, Rm86Texas, and other conserved proteins) as vaccine components. Animals are exposed to these antigens in a controlled manner to stimulate protective immunity, transforming the原本的 harmful interaction into a protective mechanism that reduces tick survival and pathogen transmission.
Solution Approach 2:
The patent introduces immunological mediators (antibodies, T-cell responses, and other immune components) as intermediaries between the tick antigens and the tick organisms. These mediators enable the host animal to recognize and respond to tick infestations, providing a biological control mechanism that bypasses pesticide resistance issues.
2Reliability
If existing arthropod parasite vaccines are used, then some protection is provided, but effectiveness is limited against multiple tick species including R. microplus, I. scapularis, and A. americanum
Solution Approach 1:
The patent achieves universal tick protection by identifying and utilizing conserved antigens that are shared across multiple tick species. Antigens such as Bm86, Rm86Texas, and other conserved proteins elicit immune responses that are effective against diverse tick species including Rhipicephalus microplus, Ixodes scapularis, and Amblyomma americanum, providing broad-spectrum protection through a single vaccine formulation.
Solution Approach 2:
The patent employs composite vaccine formulations that combine multiple tick antigens (proteins, peptides, and nucleic acid constructs) to create a multi-component immunological preparation. This composite approach ensures coverage against different tick species and life stages, enhancing overall vaccine effectiveness and versatility.
3Object-affected harmful factors
If broad spectrum protection against multiple tick species is achieved, then tick-borne disease transmission is reduced, but vaccine development complexity increases
Solution Approach 1:
The patent extracts and utilizes specific conserved antigenic components (such as Bm86, Rm86Texas, and other shared proteins) from different tick species to create simplified vaccine formulations. By focusing on these key conserved antigens rather than using whole tick preparations, the vaccine achieves broad protection while maintaining manageable formulation complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The Rm86Texas protein vaccine significantly reduces tick infestations and associated diseases in treated animals, providing a broad spectrum of protection against various tick species, thereby enhancing animal health and welfare while addressing the limitations of existing vaccines.
Implementation Method 1
Compositions of either the Rm86Texas protein from a Texas outbreak strain of the southern cattle fever tick, Rhipicephalus microplus, or a nucleic acid construct incorporating a nucleic acid sequence encoding this Rm86Texas protein, are effective for eliciting a protective immune response in non-bovine animals.
Data Source
AI summary
Compositions of either the Rm86Texas protein from a Texas outbreak strain of the southern cattle fever tick, Rhipicephalus microplus, or a nucleic acid construct incorporating a nucleic acid sequence encoding this Rm86Texas protein, are effective for eliciting a protective immune response in non-bovine animals. The Rm86Texas protein is immunogenic and can be administered as a protein vaccine, or in the alternative, the nucleic acid construct can be utilized as a DNA vaccine. Induction of the immune response significantly reduces or eliminates the infestation of treated, non-bovine animals with ticks. Moreover, as ticks are vectors of a variety of pathogens, the reduction in the incidence of tick infestation afforded by the vaccines may concurrently reduce the incidence of diseases caused by these pathogens in susceptible animals.